BackEssilorLuxottica Overview

EssilorLuxottica Total Current Liabilities

EssilorLuxottica's total current liabilities is $13B.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$12.64B
10.98% YoYΔ $1.25B vs prior year quarter

Peer average / median

Loading

EssilorLuxottica Total Current Liabilities History

Loading

EssilorLuxottica vs. peers: Total Current Liabilities Comparison

Loading

EssilorLuxottica Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

EssilorLuxottica (ESLOY) FAQ

EssilorLuxottica (ESLOY) currently reports a total current liabilities of $13B as of June 2026. That compares with $11B in the prior-year period — up 11.0% year over year. Use the charts on this page to explore EssilorLuxottica's total current liabilities history and peer comparisons.

EssilorLuxottica's total current liabilities increased from $11B to $13B — a 11.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

EssilorLuxottica reported $13B in total current liabilities as of June 2026. That compares with $11B in the prior-year period — up 11.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $13B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for EssilorLuxottica, and consider following ESLOY for alerts when major investors trade the stock.

EssilorLuxottica is classified in the Healthcare sector. On total current liabilities, it currently shows $13B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ESLOY with unrelated industries.